drugset / Trial / NCT00532428

Long Term Effects of Raloxifene Treatment on Bone Quality

NCT00532428

Phase 4 Completed 31 enrolled Eli Lilly and Company
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a cross-sectional study to determine, via iliac crest bone biopsies, the effect of long-term treatment with raloxifene on histomorphometry and bone quality in patients who participated in the Continuing Outcomes Relevant to Evista Study.

Timeline

Start
2003-04
Primary completion
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Raloxifene Other / unclassified 60 mg
Comparator Raloxifene Other / unclassified 120 mg